HA
ARKG icon

Hanover Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Hanover Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Buy
42,965
+7,376
+21% +$216K 0.46% 33
2025
Q4 		$1.03M Buy
35,589
+960
+3% +$28.8K 0.4% 35
2025
Q3 		$962K Buy
+34,629
New +$875K 0.37% 35

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Hanover Advisors's ARKG Position: Q1 2026 in Review

Hanover Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 21% in Q1 2026, buying an estimated $216K and bringing the position to 42,965 shares worth $1.14M. The position accounts for 0.46% of the portfolio, ranked #33.

Hanover Advisors first reported a position in ARKG in Q3 2025 and has held it in 3 quarters since. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Hanover Advisors held 42,965 shares of ARK Genomic Revolution ETF worth $1.14M as of Q1 2026.
  • Hanover Advisors bought 7,376 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $216K.
  • ARK Genomic Revolution ETF made up 0.46% of Hanover Advisors's portfolio in Q1 2026, its #33 holding.
  • Hanover Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 3 quarters since.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Hanover Advisors's 13F filing for Q1 2026, filed 7 May 2026.